These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32363536)

  • 1. Rifampicin loaded in alginate/chitosan nanoparticles as a promising pulmonary carrier against Staphylococcus aureus.
    Scolari IR; Páez PL; Musri MM; Petiti JP; Torres A; Granero GE
    Drug Deliv Transl Res; 2020 Oct; 10(5):1403-1417. PubMed ID: 32363536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis.
    Scolari IR; Páez PL; Sánchez-Borzone ME; Granero GE
    AAPS PharmSciTech; 2019 Jan; 20(2):67. PubMed ID: 30627867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Toxicity, Lung Distribution, and Cellular Uptake of Rifampicin and Ascorbic Acid-Loaded Alginate Nanoparticles as Therapeutic Treatment of Lung Intracellular Infections.
    Scolari IR; Volpini X; Fanani ML; La Cruz-Thea B; Natali L; Musri MM; Granero GE
    Mol Pharm; 2021 Mar; 18(3):807-821. PubMed ID: 33356316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of rifaximin loaded chitosan-alginate core-shell nanoparticles (Rif@CS/Alg-NPs) for antibacterial applications.
    Kumar D; Kumar S; Kumar S; Rohatgi S; Kundu PP
    Int J Biol Macromol; 2021 Jul; 183():962-971. PubMed ID: 33965483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication and antimicrobial properties of novel meropenem-honey encapsulated chitosan nanoparticles against multiresistant and biofilm-forming Staphylococcus aureus as a new antimicrobial agent.
    Hajimohammadi S; Momtaz H; Tajbakhsh E
    Vet Med Sci; 2024 May; 10(3):e1440. PubMed ID: 38613443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing Alginate/Chitosan Nanoparticles Containing Echinacea angustifolia: A Novel Candidate for Combating Multidrug-Resistant Staphylococcus aureus.
    Taghiloo S; Ghajari G; Zand Z; Kabiri-Samani S; Kabiri H; Rajaei N; Piri-Gharaghie T
    Chem Biodivers; 2023 Jul; 20(7):e202201008. PubMed ID: 37157889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections.
    Kaur J; Kour A; Panda JJ; Harjai K; Chhibber S
    AAPS PharmSciTech; 2020 Aug; 21(6):233. PubMed ID: 32794119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment.
    Tan CK; Lai CC; Liao CH; Lin SH; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2011 Jun; 37(6):550-3. PubMed ID: 21482080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Functionalized Polymer Nanoparticles for Targeted Antibiotic Delivery in Models of Pathogenic Bacteria Infecting Human Macrophages.
    Miranda Calderon LG; Alejo T; Santos S; Mendoza G; Irusta S; Arruebo M
    ACS Appl Mater Interfaces; 2023 Aug; 15(34):40213-40227. PubMed ID: 37596966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic.
    Costabile G; Baldassi D; Müller C; Groß B; Ungaro F; Schubert S; Firestine SM; Merkel OM
    J Control Release; 2024 Oct; 374():454-465. PubMed ID: 39181163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo and In Vitro Assessments of the Antibacterial Potential of Chitosan-Silver Nanocomposite Against Methicillin-Resistant Staphylococcus aureus-Induced Infection in Rats.
    Hassanen EI; Ragab E
    Biol Trace Elem Res; 2021 Jan; 199(1):244-257. PubMed ID: 32306284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ameliorative role of
    El-Emam MMA; El-Demerdash AS; Abdo SA; Abd-Elfatah EB; El-Sayed MM; Qelliny MR; Eldin ZE; Shehata AA
    Open Vet J; 2024 Jan; 14(1):416-427. PubMed ID: 38633182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(amino acid)-based drug delivery nanoparticles eliminate Methicillin resistant Staphylococcus aureus via tunable release of antibiotic.
    Li H; Yang L; Feng W; Liu W; Wang M; Liu F; Li G; Wang X
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113882. PubMed ID: 38593511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-printed dual drug delivery nanoparticle- loaded hydrogels to combat antibiotic-resistant bacteria.
    Martínez-Pérez D; Guarch-Pérez C; Purbayanto MAK; Choińska E; Riool M; Zaat SAJ; Wojciech Ś
    Int J Bioprint; 2023; 9(3):683. PubMed ID: 37273978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles as antibiotic-delivery vehicles (ADVs) overcome resistance by MRSA and other MDR bacterial pathogens: The grenade hypothesis.
    Alabresm A; Chen YP; Wichter-Chandler S; Lead J; Benicewicz BC; Decho AW
    J Glob Antimicrob Resist; 2020 Sep; 22():811-817. PubMed ID: 32653724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel intracellular antibiotic delivery system against
    Lacoma A; Usón L; Mendoza G; Sebastián V; Garcia-Garcia E; Muriel-Moreno B; Domínguez J; Arruebo M; Prat C
    Nanomedicine (Lond); 2020 May; 15(12):1189-1203. PubMed ID: 32370602
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin.
    Costa JR; Silva NC; Sarmento B; Pintado M
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1255-62. PubMed ID: 25754770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
    Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.